IP Library Granted Patent US 10,364,457
Granted Patent B2
US 10,364,457 · App. 15/229,539 · Granted Jul 30, 2019

Nanoscale imaging of proteins and nucleic acids via expansion microscopy

Inventors: Asmamaw Wassie (Cambridge, MA); Fei Chen (Cambridge, MA); Edward Stuart Boyden (Chestnut Hill, MA); Shahar Alon (Cambridge, MA); George Church (Brookline, MA); Evan Daugharthy (Cambridge, MA)
Assignee: Massachusetts Institute of Technology
C12Q1/6841C12Q1/6806G01N1/36G01N2001/364
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,364,457
App. No.
15/229,539
Granted
Jul 30, 2019
Kind
B2
Abstract

The invention enables in situ genomic and transcriptomic assessment of nucleic acids to be conducted in biological specimens that have been physically expanded. The invention leverages the techniques for expansion microscopy (ExM) to provide new methods for in situ genomic and transcriptomic assessment of nucleic in a new process referred to herein as “expansion fluorescent in situ hybridization” (ExFISH).

Claims (20)

1. A method for in situ genomic and transcriptomic assessment of target nucleic acids present in a biological sample comprising the steps of:

a) treating the biological sample with a small molecule linker comprising a chemical reactive group capable of covalently binding at least one target nucleic acid and a chemical group that can be incorporated into the a swellable material;

b) permeating the biological sample with a composition comprising precursors of a swellable material;

c) initiating polymerization of the precursors to form a swellable material, wherein the small molecule linker is bound to the at least one target nucleic acid in the biological sample and to the swellable material;

d). subjecting the biological sample to a physical disruption method;

e). swelling the swellable material to form an expanded biological sample;

f). providing at least one oligonucleotide complementary to the at least one target nucleic acid, wherein the at least one oligonucleotide hybridizes to the at least one target nucleic acid; and

g). genomically or transcriptomically assessing the expanded biological sample.

2. The method according to claim 1 , wherein the small molecule linker is labeled.

3. The method according to claim 2 , wherein the expanded biological sample expresses one or more labeled target nucleic acids.

4. The method according to claim 1 , wherein the at least one oligonucleotide is labeled.

5. The method according to claim 1 , wherein the at least one target nucleic acid is anchored to the swellable material.

6. The method according to claim 1 , wherein the physical disruption method is an enzymatic digestion.

7. The method according to claim 1 , wherein the target nucleic acids are DNA and/or RNA.

8. The method according to claim 1 , further comprising the additional step of buffering the expanded sample.

9. The method according to claim 8 , further comprising the additional step of re-embedding the buffered expanded biological sample in a non-swellable material.

10. The method according to claim 9 , further comprising the step of removing the at least one oligonucleotide complementary to the at least one target nucleic acid.

11. The method according to claim 10 , wherein the steps of providing at least one oligonucleotide, genomically or transcriptomically assessing the expanded biological sample and removing the at least one oligonucleotide are repeated so as to allow serial or sequential genomic or transcriptomic assessments of the expanded biological sample.

12. The method of claim 10 , wherein removing the at least one oligonucleotide which is hybridized to the at least one target nucleic acid comprises formamide and high temperatures.

13. The method of claim 10 , wherein removing the at least one oligonucleotide which is hybridized to the at least one target nucleic acid comprises endonucleases that specifically digest the at least one oligonucleotide.

Assignments (4)
CONFIRMATORY LICENSE Recorded Jan 31, 2019
From: MASSACHUSETTS INSTITUTE OF TECHNOLOGY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 048199/0074 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 17, 2018
From: CHURCH, GEORGE M.; DAUGHARTHY, EVAN R.
To: PRESIDENT AND FELLOWS OF HARVARD COLLEGE
Reel/Frame 045835/0755 →
CONFIRMATORY LICENSE Recorded Apr 27, 2017
From: MASSACHUSETTS INSTITUTE OF TECHNOLOGY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 042352/0339 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 3, 2016
From: WASSIE, ASMAMAW; CHEN, FEI; BOYDEN, EDWARD STUART; ALON, SHAHAR
To: MASSACHUSETTS INSTITUTE OF TECHNOLOGY
Reel/Frame 039919/0152 →
Continuity (2)
Provisional Application 62202421 · Aug 7, 2015
Related Publication 20170067096A1 · Mar 9, 2017
Cited By (52)
US 12,188,085 US 12,188,087 US 12,188,855 US 12,203,136 US 12,209,273 US 12,215,379 US 12,227,796 US 12,233,184 US 12,234,507 US 12,258,454 US 12,258,624 US 12,264,358 US 12,265,004 US 12,270,071 US 12,270,074 US 12,275,984 US 12,297,499 US 12,319,956 US 12,325,877 US 12,331,347 US 12,360,105 US 12,365,944 US 12,391,984 US 12,400,733 US 12,405,193 US 12,435,364 US 12,460,251 US 12,467,086 US 12,497,653 US 12,509,717 US 12,510,744 US 12,516,369 US 12,529,096 US 12,553,079 US 12,559,790 US 12,559,791 US 12,565,671 US 12,618,099 US 12,646,340 US 12,655,474 US 12,662,699 US 12,674,196 US 12,687,494 US 12,692,484 US 12,703,879 US 12,709,771 US 12,716,086 US 12,716,092 US 12,718,518 US 12,723,275 US 12,730,295 US 12,735,738